Plain-English translation of NCT03941756 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a procedure called lymphovenous bypass can help prevent lymphedema—painful arm swelling that sometimes happens after lymph node removal surgery. About half of participants will receive the bypass procedure during their standard lymph node removal surgery, while the other half will receive only the standard surgery. Researchers will then follow both groups for 18 months to see if the bypass surgery reduces swelling.
Lymphedema (arm swelling) is a common and difficult side effect for people with advanced breast cancer or melanoma who need their underarm lymph nodes removed. This trial exists to find out whether doing a special bypass procedure at the same time as lymph node removal might prevent this swelling from happening in the first place.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will be randomly assigned to one of two groups: one group receives the bypass procedure during their lymph node removal surgery, and the other group receives only the standard surgery. After your surgery, you will have follow-up visits at 2 weeks, then at 6, 12, and 18 months to check for swelling and measure how well your arm is functioning. Your care team will track whether you develop lymphedema and compare outcomes between the two groups.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
United States